je.st
news
Ackman says Allergan holders back takeover at $180/shr: CNBC
2014-06-09 20:43:11| Biotech - Topix.net
Activist investor William Ackman on Monday defended Valeant Pharmaceuticals during an interview on CNBC television and said that Allergan Inc shareholders told him they would support a deal at $180 per share.
Tags: back
holders
takeover
cnbc
Category:Biotechnology and Pharmaceuticals